Advertisement

Picture EBD Group BioTech Showcase 2020 San Francisco BEU2020 650x76px
Organisation › Details

Vinci Capital-Renaissance PME

Vinci Capital is a leading Swiss private equity firm with over MCHF 200 under management. Since 1998 Vinci Capital has provided equity to over 30 Swiss technology and industrial companies to finance innovation, growth and succession-buyouts. Vinci Capital has an exclusive mandate to manage the funds of Renaissance PME and Mona Lisa AG. Renaissance PME is a foundation dedicated to Swiss pension funds to provide them with a fiscallyoptimized and regulated vehicle for direct private-equity investments. Mona Lisa AG is an investment holding funded by Swisscom dedicated to financing innovative Swiss SMEs with high growth potential. For further information please visit www.renaissance-pme.ch and www.vincicapital.ch *

 

Period Start 2011-03-28 existent
  Group Vinci Capital
Products Industry venture capital
  Industry 2 LIFE SCIENCES
     
Region Region Lausanne VD
  Country Switzerland
  Street PSE, Bâtiment C
  City 1015 Lausanne VD
    Address record changed: 2011-05-14
     
Basic data Employees n. a.
     
    * Document for �About Section�: Anergis S.A.. (3/28/11). "Press Release: Anergis Closes CHF 18 Million Series A Financing Round to Develop Its Innovative Allergy Vaccines and Expands Its Board of Directors". Lausanne.
     
   
Record changed: 2017-04-01

Advertisement

Picture [LSA] Life-Sciences-Asia.com – The Business Web Portal 650x89px

More documents for Vinci Capital


To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]

Advertisement

Picture EBD Group BioTech Showcase 2020 San Francisco BEU2020 650x76px




» top